Back To Index << Back To Terminology

# Value Set NFDI4Health_VS_MDS_Study_Intervention_Type_NCI_Local 2023‑10‑25 12:39:46

This terminology is a snapshot as of 2025‑06‑02 12:00:33. Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.
Id | 2.16.840.1.113883.3.1937.777.64.11.65 | Effective Date | 2023‑10‑25 12:39:46
Status | Cancelled | Version Label |
Name | NFDI4Health_VS_MDS_Study_Intervention_Type_NCI_Local | Display Name | NFDI4Health_VS_MDS_Study_Intervention_Type_NCI_Local
A valid code from the code system:
Code System Name | Code System Id | Flexibility
NCI Metathesaurus | 2.16.840.1.113883.3.26.1.2 | DYNAMIC
Or one of the following:
Source Code System | 2.16.840.1.113883.3.1937.777.64.5.1 - NFDI4Health_CS_MDS_Remaining_Concepts - FHIR: urn:oid:2.16.840.1.113883.3.1937.777.64.5.1
Level/ Type | Code | Display Name / Intensional Definition | Code System | Code System Version | Description
--- | --- | --- | --- | --- | ---
0‑L | 001 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Minimum age of examined subjects
0‑L | 002 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Maximum age of examined subjects
0‑L | 003 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Case-only
0‑L | 004 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Case-cohort
0‑L | 005 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Trend
0‑L | 006 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cross-section ad-hoc follow-up
0‑L | 007 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Quality control studies
0‑L | 008 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Respondent-driven sampling
0‑L | 009 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Data dictionary
0‑L | 010 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Analytic code
0‑L | 011 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Codebook
0‑L | 012 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Outcomes assessor
0‑L | 013 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | All rights reserved
0‑L | 014 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Intervention ongoing
0‑L | 015 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Intervention completed, follow-up ongoing
0‑L | 016 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Interview schema and themes
0‑L | 017 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Observation guide
0‑L | 018 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Discussion guide
0‑L | 019 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Participant tasks
0‑L | 020 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Other data collection instrument
0‑L | 021 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Other study document
0‑L | 022 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Not yet recruiting
0‑L | 023 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Enrolling by invitation
0‑L | 024 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Active, not recruiting
0‑L | 025 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Withdrawn
0‑L | 026 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Request for approval not yet submitted
0‑L | 027 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Study withdrawn prior to decision on approval
0‑L | 028 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Administrative databases
0‑L | 029 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cognitive measurements
0‑L | 030 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Genealogical records
0‑L | 031 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Imaging data
0‑L | 032 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Physiological/Biochemical measurements
0‑L | 033 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Omics technology
0‑L | 034 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Probability Sampling Method
0‑L | 035 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Mixed Probability and Non-Probability Sampling Method
0‑L | 036 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Total universe/Complete enumeration
0‑L | 037 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Primary Sponsor
0‑L | 038 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Data Collector
0‑L | 039 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Data Curator
0‑L | 041 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Project Manager
0‑L | 042 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Project Member
0‑L | 043 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Related Person
0‑L | 044 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Rights Holder
0‑L | 045 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Work Packager Leader
0‑L | 046 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Public Funder
0‑L | 047 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Private Funder
0‑L | 048 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Research Group
0‑L | 049 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Hosting Institution
0‑L | 050 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Registration Agency
0‑L | 051 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Computational Notebook
0‑L | 052 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Data Paper
0‑L | 053 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Interactive Resource
0‑L | 054 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Output Management Plan
0‑L | 040 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Project Leader
0‑L | 055 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is cited by B
0‑L | code-58 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A cites B
0‑L | 057 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is supplemented by B
0‑L | 058 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is continued by B
0‑L | 059 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is described by B
0‑L | 060 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A describes B
0‑L | 061 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is metadata for B
0‑L | 062 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A has version B
0‑L | 063 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is version of B
0‑L | 064 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is previous version of B
0‑L | 065 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is part of B
0‑L | 066 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is referenced by B
0‑L | 067 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is documented by B
0‑L | 068 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is compiled by B
0‑L | 069 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A compiles B
0‑L | 070 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is variant form of B
0‑L | 071 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is original form of B
0‑L | 072 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is identical to B
0‑L | 073 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is reviewed by B
0‑L | 074 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A reviews B
0‑L | 075 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is source of B
0‑L | 076 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is required by B
0‑L | 077 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A requires B
0‑L | 078 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is obsoleted by B
0‑L | 079 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A obsoletes B
0‑L | 080 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ORCID
0‑L | 081 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ROR
0‑L | 082 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | GRID
0‑L | 083 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ISNI
0‑L | 084 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Monocentric
0‑L | 085 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | First submitted
0‑L | 086 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | First posted
0‑L | 087 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Last update submitted
0‑L | 088 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Last update posted
0‑L | 089 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | arXiv
0‑L | 090 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | EAN13
0‑L | 091 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | EISSN
0‑L | 092 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ISBN
0‑L | 093 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ISSN
0‑L | 094 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ISTC
0‑L | 095 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | LISSN
0‑L | 096 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | PURL
0‑L | 097 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | w3id
0‑L | 098 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | DRKS
0‑L | 099 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | ISRCTN
0‑L | 100 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | EUDAMED
0‑L | 101 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | UTN
0‑L | 102 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | KonsortSWD
0‑L | 103 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | MDM Portal
0‑L | 104 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | NFDI4Health
0‑L | 105 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | diverse
0‑L | 106 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | NCT (ClinicalTrials.gov)
0‑L | 107 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | EudraCT
0‑L | 108 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is supplement to B
0‑L | 109 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A continues B
0‑L | 110 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A has metadata B
0‑L | 111 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is new version of B
0‑L | 112 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A has part B
0‑L | 113 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A references B
0‑L | 114 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A documents B
0‑L | 115 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | A is derived from B
0‑L | 116 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Self-report (questionnaires or interviews), cases verified
0‑L | 117 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Self-report (questionnaires or interviews), cases not verified
0‑L | 118 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | 24-h dietary recall
0‑L | 119 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Proxy-administered
0‑L | 120 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Food record
0‑L | 121 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Described portion sizes
0‑L | 122 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Picture book/visual aids
0‑L | 123 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Weighing
0‑L | 124 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Volume measures
0‑L | 125 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Online questionnaire
0‑L | 126 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cluster
0‑L | 127 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cluster: Simple random
0‑L | 128 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cluster: Stratified random
0‑L | 129 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Screener
0‑L | 130 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Interventional
0‑L | 131 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Non-interventional
0‑L | 132 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Vaccine and biological substance (Pharmacologic Substance)
0‑L | 133 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Single Group
0‑L | 134 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Parallel
0‑L | 135 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Crossover
0‑L | 136 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Factorial
0‑L | 137 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Sequential
0‑L | 138 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Other (interventional)
0‑L | 139 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Unknown (interventional)
0‑L | 140 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Case-control
0‑L | 141 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Nested case-control
0‑L | 142 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Case-crossover
0‑L | 143 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Ecologic or community studies
0‑S | 144 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Family-based
1‑L | 161 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Conditions related to sexual health
0‑L | 145 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Twin study
0‑L | 146 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cohort
0‑L | 147 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Birth cohort
0‑L | 148 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Panel
0‑L | 149 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Longitudinal
0‑L | 150 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cross-section
0‑L | 151 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Time series
0‑L | 152 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Registry
0‑L | 153 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Other (non-inverventional)
0‑L | 154 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Unknown (non interventional)
0‑L | 155 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Retrospective
0‑L | 156 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Prospective
0‑L | 157 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Nonrandomized
0‑L | 158 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Not applicable (for single-arm trials)
0‑L | 159 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Randomized
0‑L | 160 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Non-probability
0‑L | 162 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Cross-sectional (timePerspectives)
0‑L | 163 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Other (timePerspectives)
0‑L | 164 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Other (method)
0‑L | 165 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Unknown (method)
0‑L | 166 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Not applicable (method)
0‑L | 167 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Simple random
0‑L | 168 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Systematic random
0‑L | 169 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Stratified
0‑L | 170 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Stratified: Proportional
0‑L | 171 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Stratified: Disproportional
0‑L | 172 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Multistage
0‑L | 173 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Quota
0‑L | 174 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Purposive
0‑L | 175 |  | NFDI4Health_CS_MDS_Remaining_Concepts | 2023-08-30T20:56:25 | Availability
0‑L | C1909 | Pharmacologic Substance (Pharmacologic Substance) | NCI Metathesaurus |  |
0‑L | C17649 | Other (Qualitative Concept) | NCI Metathesaurus |  |
0‑L | C17454 | Diagnostic Test (Diagnostic Procedure) | NCI Metathesaurus |  |
0‑L | C54696 | Combination Product (Manufactured Object) | NCI Metathesaurus |  |
0‑L | C1505 | Dietary Supplement (Food) | NCI Metathesaurus |  |
0‑L | C17938 | Genetic (Functional Concept) | NCI Metathesaurus |  |
0‑L | C15184 | Behavioral Intervention (Therapeutic or Preventive Procedure) | NCI Metathesaurus |  |
0‑L | C61398 | Radiation Exposure (Phenomenon or Process) | NCI Metathesaurus |  |
0‑L | C79751 | Procedure (Activity) | NCI Metathesaurus |  |
0‑L | C62103 | Device (Manufactured Object) | NCI Metathesaurus |  |
0‑L | 132 | Vaccine and biological substance (Pharmacologic Substance) | NFDI4Health_CS_MDS_Remaining_Concepts |  |
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.
This value set is an intensional definition that is defined by filters and rules rather than listing codes explicitly.
| XML JSON CSV SQL SVS FHIR (4.0)